Photoreactive regulator of glutamate receptor function and methods of use thereof
View Patent ↗The present invention provides a synthetic regulator of glutamate receptor function, which regulator is a light-sensitive (photoreactive) regulator. The present invention further provides a light-regulated glutamate receptor that includes a subject synthetic regulator non-covalently associated with the glutamate receptor. Also provided are cells and membranes comprising a subject light-regulated glutamate receptor. The present invention further provides methods of modulating glutamate receptor function, involving use of light. The present invention further provides methods of identifying agents that modulate glutamate receptor function.
1. A synthetic regulator of glutamate receptor function, the regulator comprising:
a) a photoisomerizable group selected from an azobenzene, a fulgide, a spiropyran, a triphenyl methane, a thioindigo, a diarylethene, and an overcrowded alkene;
b) a ligand that binds to a ligand binding site of said glutamate receptor, wherein the ligand is selected from the group consisting of glutamate, methylglutamate, 4-allyl glutamate, N-methyl-D-aspartate, D-serine, or glycine,
wherein the ligand is covalently linked to the photoisomerizable group, and
wherein the synthetic regulator does not comprise a linker domain comprising a binding moiety that provides for stable association with the glutamate receptor.
2. The synthetic regulator of claim 1 , wherein the photoisomerizable group comprises an azobenzene.
3. The synthetic regulator of claim 1 , wherein photoisomerization of the photoisomerizable group results in a change in the binding of the ligand to the ligand-binding site, thereby regulating the function of said glutamate receptor.
4. The synthetic regulator of claim 1 , wherein the glutamate receptor is an ionotropic glutamate receptor.
5. The synthetic regulator of claim 4 , wherein the ionotropic glutamate receptor is an N-methyl-D-aspartate (NMDA) receptor, an α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor, or a kainate (KA) receptor.
6. The synthetic regulator of claim 1 , wherein the synthetic regulator has the structure:
7. A pharmaceutical composition comprising:
a) the synthetic regulator of claim 1 ; and
b) a pharmaceutically acceptable excipient.